Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Heron Therapeutics Gross Margin 2010-2024 | HRTX

Current and historical gross margin for Heron Therapeutics (HRTX) over the last 10 years. The current gross profit margin for Heron Therapeutics as of March 31, 2024 is %.
  
Heron Therapeutics Gross Margin Historical Data
Date TTM Revenue TTM Gross Profit Gross Margin
2024-03-31 $0.13B $0.08B 56.82%
2023-12-31 $0.13B $0.06B 48.82%
2023-09-30 $0.12B $0.06B 44.72%
2023-06-30 $0.12B $0.05B 45.38%
2023-03-31 $0.12B $0.05B 46.09%
2022-12-31 $0.11B $0.05B 48.15%
2022-09-30 $0.10B $0.05B 45.45%
2022-06-30 $0.10B $0.05B 47.37%
2022-03-31 $0.09B $0.04B 47.19%
2021-12-31 $0.09B $0.04B 47.67%
2021-09-30 $0.09B $0.04B 48.84%
2021-06-30 $0.08B $0.04B 51.81%
2021-03-31 $0.08B $0.05B 58.33%
2020-12-31 $0.09B $0.05B 59.55%
2020-09-30 $0.10B $0.06B 59.22%
2020-06-30 $0.13B $0.07B 57.94%
2020-03-31 $0.14B $0.08B 58.57%
2019-12-31 $0.15B $0.08B 57.14%
2019-09-30 $0.14B $0.08B 58.16%
2019-06-30 $0.12B $0.07B 58.47%
2019-03-31 $0.10B $0.06B 59.18%
2018-12-31 $0.08B $0.05B 62.82%
2018-09-30 $0.06B $0.04B 69.49%
2018-06-30 $0.05B $0.04B 77.08%
2018-03-31 $0.04B $0.03B 80.00%
2017-12-31 $0.03B $0.03B 81.25%
2011-12-31 $0.00B 0 nan%
2011-06-30 $0.00B 0 nan%
2011-03-31 $0.00B $0.00B 100.00%
2010-12-31 $0.00B $0.00B 100.00%
2010-09-30 $0.00B $0.00B 100.00%
2010-06-30 $0.00B $0.00B 100.00%
2010-03-31 $0.00B $0.00B 100.00%
2009-12-31 $0.00B $0.00B 100.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.417B $0.127B
Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $80.125B 32.58
Chugai Pharmaceutical (CHGCY) Japan $60.930B 27.24
Takeda Pharmaceutical (TAK) Japan $41.491B 8.40
Merck (MKGAF) Germany $21.325B 20.68
Astellas Pharma (ALPMY) Japan $17.744B 28.01
Sandoz Group AG (SDZNY) Switzerland $15.663B 0.00
Neurocrine Biosciences (NBIX) United States $13.911B 38.08
United Therapeutics (UTHR) United States $13.796B 14.71
Shionogi (SGIOY) Japan $11.343B 9.86
Catalent (CTLT) United States $10.227B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.342B 0.00
Ionis Pharmaceuticals (IONS) United States $6.656B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.529B 7.17
Revolution Medicines (RVMD) United States $6.091B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.790B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Summit Therapeutics (SMMT) United States $4.837B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.486B 0.00
Corcept Therapeutics (CORT) United States $3.175B 28.77
Arrowhead Pharmaceuticals (ARWR) United States $3.114B 0.00
Dyne Therapeutics (DYN) United States $2.979B 0.00
PTC Therapeutics (PTCT) United States $2.378B 0.00
Indivior (INDV) United States $2.104B 9.97
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.083B 11.84
Evotec AG (EVO) Germany $1.825B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.808B 17.60
NewAmsterdam Pharma (NAMS) Netherlands $1.800B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.747B 0.00
Soleno Therapeutics (SLNO) United States $1.404B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.397B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.323B 0.00
Ardelyx (ARDX) United States $1.238B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.169B 0.00
Xencor (XNCR) United States $1.148B 0.00
4D Molecular Therapeutics (FDMT) United States $1.078B 0.00
Collegium Pharmaceutical (COLL) United States $1.059B 6.33
Ocular Therapeutix (OCUL) United States $1.036B 0.00
Enliven Therapeutics (ELVN) United States $1.014B 0.00
Pacira BioSciences (PCRX) United States $1.008B 9.58
Ironwood Pharmaceuticals (IRWD) United States $0.956B 14.90
Cronos Group (CRON) Canada $0.887B 0.00
ARS Pharmaceuticals (SPRY) United States $0.881B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.862B 0.00
USANA Health Sciences (USNA) United States $0.857B 14.01
Relay Therapeutics (RLAY) United States $0.832B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.780B 0.00
Harrow (HROW) United States $0.764B 0.00
Exscientia (EXAI) United Kingdom $0.649B 0.00
Sage Therapeutics (SAGE) United States $0.639B 0.00
Savara (SVRA) United States $0.598B 0.00
Siga Technologies (SIGA) United States $0.550B 7.04
Silence Therapeutics (SLN) United Kingdom $0.538B 0.00
ProKidney (PROK) United States $0.534B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.531B 0.00
Cassava Sciences (SAVA) United States $0.517B 0.00
KalVista Pharmaceuticals (KALV) United States $0.494B 0.00
Lexeo Therapeutics (LXEO) United States $0.491B 0.00
Larimar Therapeutics (LRMR) United States $0.487B 0.00
Altimmune (ALT) United States $0.468B 0.00
Bioventus (BVS) United States $0.466B 17.85
Esperion Therapeutics (ESPR) United States $0.447B 0.00
Verve Therapeutics (VERV) United States $0.432B 0.00
OmniAb (OABI) United States $0.429B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.414B 0.00
Lyell Immunopharma (LYEL) United States $0.385B 0.00
Organogenesis (ORGO) United States $0.370B 69.75
Korro Bio (KRRO) United States $0.355B 0.00
Tourmaline Bio (TRML) United States $0.329B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.318B 0.00
Xeris Biopharma Holdings (XERS) United States $0.308B 0.00
Nature's Sunshine Products (NATR) United States $0.281B 17.86
Enanta Pharmaceuticals (ENTA) United States $0.278B 0.00
Nanobiotix S.A (NBTX) France $0.254B 0.00
Black Diamond Therapeutics (BDTX) United States $0.250B 0.00
Foghorn Therapeutics (FHTX) United States $0.239B 0.00
Nektar Therapeutics (NKTR) United States $0.239B 0.00
Aquestive Therapeutics (AQST) United States $0.219B 0.00
Fractyl Health (GUTS) United States $0.214B 0.00
ESSA Pharma (EPIX) Canada $0.212B 0.00
Profound Medical (PROF) Canada $0.212B 0.00
Eliem Therapeutics (ELYM) United States $0.204B 0.00
Avita Medical (RCEL) United States $0.201B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Prelude Therapeutics (PRLD) United States $0.199B 0.00
Akebia Therapeutics (AKBA) United States $0.198B 0.00
Elite Pharmaceuticals (ELTP) United States $0.197B 18.45
Century Therapeutics (IPSC) United States $0.192B 0.00
Aldeyra Therapeutics (ALDX) United States $0.190B 0.00
Acrivon Therapeutics (ACRV) United States $0.190B 0.00
Zevra Therapeutics (ZVRA) United States $0.180B 0.00
Incannex Healthcare (IXHL) Australia $0.174B 0.00
Pyxis Oncology (PYXS) United States $0.170B 0.00
Achieve Life Sciences (ACHV) Canada $0.155B 0.00
Metagenomi (MGX) United States $0.146B 0.00
CytoDyn (CYDY) United States $0.138B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.136B 0.00
MediWound (MDWD) Israel $0.135B 0.00
Context Therapeutics (CNTX) United States $0.134B 0.00
Galectin Therapeutics (GALT) United States $0.134B 0.00
Cardiol Therapeutics (CRDL) Canada $0.132B 0.00
Assertio Holdings (ASRT) United States $0.129B 5.91
Amylyx Pharmaceuticals (AMLX) United States $0.120B 8.05
OptiNose (OPTN) United States $0.119B 0.00
Regulus Therapeutics (RGLS) United States $0.118B 0.00
VAXART, INC (VXRT) United States $0.114B 0.00
Telomir Pharmaceuticals (TELO) United States $0.111B 0.00
Karyopharm Therapeutics (KPTI) United States $0.103B 0.00
Journey Medical (DERM) United States $0.103B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
Citius Pharmaceuticals (CTXR) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.087B 0.00
AlloVir (ALVR) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
PMV Pharmaceuticals (PMVP) United States $0.080B 0.00
Arch Biopartners (ACHFF) Canada $0.078B 0.00
SCYNEXIS (SCYX) United States $0.073B 1.03
CASI Pharmaceuticals (CASI) China $0.070B 0.00
ProPhase Labs (PRPH) United States $0.069B 0.00
FibroGen (FGEN) United States $0.069B 0.00
Vivani Medical (VANI) United States $0.067B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.066B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Nutriband (NTRB) United States $0.063B 0.00
Carisma Therapeutics (CARM) United States $0.058B 0.00
Mural Oncology (MURA) Ireland $0.051B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.050B 0.00
Conduit Pharmaceuticals (CDT) United States $0.047B 0.00
Tempest Therapeutics (TPST) United States $0.047B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.046B 0.00
Inotiv (NOTV) United States $0.044B 0.00
Protara Therapeutics (TARA) United States $0.043B 0.00
BioLineRx (BLRX) Israel $0.042B 0.00
Lipocine (LPCN) United States $0.042B 0.00
DURECT (DRRX) United States $0.040B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Surrozen (SRZN) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Natural Alternatives (NAII) United States $0.034B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.030B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
NRx Pharmaceuticals (NRXP) United States $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.027B 0.00
BioVie (BIVI) United States $0.025B 0.00
Minerva Neurosciences (NERV) United States $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 0.00
Oncternal Therapeutics (ONCT) United States $0.021B 0.00
Gain Therapeutics (GANX) United States $0.021B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
PolyPid (PYPD) Israel $0.019B 0.00
Viracta Therapeutics (VIRX) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.72
JanOne (JAN) United States $0.019B 0.00
Iterum Therapeutics (ITRM) Ireland $0.019B 0.00
Unicycive Therapeutics (UNCY) United States $0.018B 0.00
SHINECO (SISI) China $0.018B 0.00
TherapeuticsMD (TXMD) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.018B 0.00
GlycoMimetics (GLYC) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Talphera (TLPH) United States $0.016B 0.00
Cosmos Health (COSM) Greece $0.015B 0.00
Mannatech (MTEX) United States $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Dominari Holdings (DOMH) United States $0.012B 0.00
Universe Pharmaceuticals INC (UPC) China $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.001B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.001B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 4.81
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 30.48